QuidelOrtho Corporation announced the appointments of John R. Chiminski and R. Scott Huennekens to its board of directors, effective December 6, 2024. These appointments align with the company's commitment to maintaining a strong, independent Board with a diverse mix of expertise and experience.
Mr. Chiminski brings a diversified medical diagnostics and pharmaceutical background, having served as CEO and Chair of Catalent, and President and CEO of GE Medical Diagnostics. Mr. Huennekens is a successful MedTech CEO and board member, with prior leadership roles at Verb Surgical and Volcano Corporation.
These additions expand the Board to 11 directors, with 10 being independent, following the resignations of James R. Prutow and Robert R. Schmidt on November 21, 2024. The new directors are expected to contribute to the company's growth and transformation plans, leveraging their proven track records in the healthcare industry.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.